Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 93,568 shares at $16.49 ($1.6M) on 2023-06-26, disclosed to the SEC on 2023-06-28.
Scheduled sale ($1.6M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.49 | 10,862 | $179K | 11.4% |
| 2 | $16.49 | 10,862 | $179K | 11.4% |
| 3 | $17.24 | 6,370 | $110K | 7.0% |
| 4 | $17.24 | 6,370 | $110K | 7.0% |
| 5 | $16.73 | 7,893 | $132K | 8.4% |
| 6 | $16.73 | 7,893 |
| $132K |
| 8.4% |
| 7 | $17.09 | 8,135 | $139K | 8.8% |
| 8 | $17.09 | 8,135 | $139K | 8.8% |
| 9 | $16.91 | 13,524 | $229K | 14.5% |
| 10 | $16.91 | 13,524 | $229K | 14.5% |
| Total | $16.86 avg | 93,568 | $1.6M | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |